Floatz logo

373 assets in Non-Hodgkin Lymphoma

Therapeutic assets addressing Non-Hodgkin Lymphoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Cyclosporin A
Non-Hodgkin Lymphoma
Memorial Sloan Kettering Cancer CenterP3BBB (76)
Adriamycin
Non-Hodgkin Lymphoma
National Cancer Institute (NCI)P4BBB (74)
Prednisolone
Non-Hodgkin Lymphoma
Mwanasha Merrill, MDP3BBB (74)
Cyclophosphamide
Non-Hodgkin Lymphoma
National Cancer Institute (NCI)P4BBB (73)
Rituximab
Non-Hodgkin Lymphoma
National Cancer Institute (NCI)P4BBB (73)
Prednisone
Non-Hodgkin Lymphoma
National Cancer Institute (NCI)P3BBB (72)
Nivestim
Non-Hodgkin Lymphoma
Thomas Jefferson UniversityP4BB (71)
Pegfilgrastim
Non-Hodgkin Lymphoma
University of WashingtonP4BB (71)
(+)-Vincristine
Non-Hodgkin Lymphoma
Mwanasha Merrill, MDP3BB (71)
Bendamustine
Non-Hodgkin Lymphoma
MEI Pharma, Inc.P3BB (70)
Tazemetostat
Non-Hodgkin Lymphoma
SWOG Cancer Research NetworkP2BB (70)
Cytarabine
Non-Hodgkin Lymphoma
Mwanasha Merrill, MDP3BB (69)
Plerixafor
Non-Hodgkin Lymphoma
Thomas Jefferson UniversityP4BB (69)
Dexasone
Non-Hodgkin Lymphoma
Mwanasha Merrill, MDP3BB (68)
Etoposide
Non-Hodgkin Lymphoma
Memorial Sloan Kettering Cancer CenterP3BB (68)
Methotrexate
Non-Hodgkin Lymphoma
Sun Yat-sen UniversityP3BB (68)
Mosunetuzumab
Non-Hodgkin Lymphoma
Bristol-Myers SquibbP3BB (68)
Obinutuzumab
Non-Hodgkin Lymphoma
National Cancer Institute (NCI)P3BB (68)
Tacrolimus
Non-Hodgkin Lymphoma
Memorial Sloan Kettering Cancer CenterP3BB (68)
Pirtobrutinib
Non-Hodgkin Lymphoma
Eli Lilly and CompanyP4BB (67)
Thiotepa
Non-Hodgkin Lymphoma
Memorial Sloan Kettering Cancer CenterP3BB (67)
Vincristine Sulfate
Non-Hodgkin Lymphoma
National Cancer Institute (NCI)P3BB (67)
Axicabtagene Ciloleucel
Non-Hodgkin Lymphoma
Lyell Immunopharma, Inc.P3BB (66)
Ibrutinib
Non-Hodgkin Lymphoma
Yazeed SawalhaP4BB (66)
Isocyclophosphamide
Non-Hodgkin Lymphoma
The Affiliated People's Hospital of Ningbo UniversityP3BB (66)
Lenalidomide
Non-Hodgkin Lymphoma
University of CologneP3BB (66)
Melphalan
Non-Hodgkin Lymphoma
Masonic Cancer Center, University of MinnesotaP2BB (66)
Nivolumab
Non-Hodgkin Lymphoma
University of PittsburghP2/3BB (66)
Pembrolizumab
Non-Hodgkin Lymphoma
Seda S. ToluP2BB (66)
Sirolimus
Non-Hodgkin Lymphoma
Umoja BiopharmaP3BB (66)
Tisagenlecleucel
Non-Hodgkin Lymphoma
Shanghai Ming Ju Biotechnology Co., Ltd.P3BB (66)
Brentuximab Vedotin
Non-Hodgkin Lymphoma
New York Medical CollegeP3BB (65)
Fludarabine
Non-Hodgkin Lymphoma
Memorial Sloan Kettering Cancer CenterP3BB (65)
Jcar-017 Cd19-Specific Chimeric Antigen Receptor
Non-Hodgkin Lymphoma
Lyell Immunopharma, Inc.P3BB (65)
Polatuzumab Vedotin
Non-Hodgkin Lymphoma
GenmabP3BB (65)
Temsirolimus
Non-Hodgkin Lymphoma
Canadian Cancer Trials GroupP4BB (65)
Acalabrutinib
Non-Hodgkin Lymphoma
Narendranath EpperlaP2BB (64)
Anti-Human T-Lymphocyte Immunoglobulin, Rabbit
Non-Hodgkin Lymphoma
Masonic Cancer Center, University of MinnesotaP2BB (64)
Bortezomib
Non-Hodgkin Lymphoma
OHSU Knight Cancer InstituteP3BB (64)
Busulfanum
Non-Hodgkin Lymphoma
City of Hope Medical CenterP2BB (64)
Camustine
Non-Hodgkin Lymphoma
VIVUS LLCP3BB (64)
Cis-Diamminedichloroplatinum Ii
Non-Hodgkin Lymphoma
The Affiliated People's Hospital of Ningbo UniversityP3BB (64)
Diphenhydramine
Non-Hodgkin Lymphoma
CellCentric Ltd.P2BB (64)
Irinotecan
Non-Hodgkin Lymphoma
M.D. Anderson Cancer CenterP2BB (64)
Mitoxantrone
Non-Hodgkin Lymphoma
The First Affiliated Hospital of Soochow UniversityP3BB (64)
Olaparib
Non-Hodgkin Lymphoma
OHSU Knight Cancer InstituteP2BB (64)
Oxaliplatin
Non-Hodgkin Lymphoma
Hoffmann-La RocheP3BB (64)
Rondecabtagene Autoleucel
Non-Hodgkin Lymphoma
Lyell Immunopharma, Inc.P3BB (64)
Treosulfan
Non-Hodgkin Lymphoma
Federal Research Institute of Pediatric Hematology, Oncology and ImmunologyP2/3BB (64)
Carboplatin
Non-Hodgkin Lymphoma
The Affiliated People's Hospital of Ningbo UniversityP3B (63)
Showing 1 to 50 of 373 assets
PreviousPage 1 of 8Next